Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease

Po Hui Wang, Yu Fan Liu, Hsiu Ting Tsai, Yi Torng Tee, Long Yau Lin, Yi Hsien Hsieh, Shun Fa Yang

研究成果: 雜誌貢獻文章同行評審

9 引文 斯高帕斯(Scopus)


Our purpose here was to detect the association among plasma osteopontin concentration, single nucleotide polymorphisms (SNPs) of osteopontin gene, and pelvic inflammatory disease (PID). The enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) were respectively used to measure the plasma osteopontin level and its gene polymorphisms. The level of plasma osteopontin was elevated in patients with PID as compared to that of healthy women and decreased significantly after treatment. Plasma osteopontin concentration was significantly correlated with white blood cell (WBC) and neutrophil counts and plasma C-reactive protein (CRP) level in patients with PID. No significant difference was found in the genotypes or alleles distribution of osteopontin SNPs, rs1126616 or rs9138, between patients with PID and normal controls. Plasma osteopontin concentration was not associated with osteopontin polymorphism. When the cutoff level of the plasma osteopontin concentration was set to be 58.53 ng/mL, the adjusted odds ratio of plasma osteopontin for PID risk was 3.87 (95% confident interval: 1.30-11.51). Plasma osteopontin level may act as a prediction marker for PID.

頁(從 - 到)1052-1058
期刊Reproductive Sciences
出版狀態已發佈 - 十一月 2010

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

指紋 深入研究「Elevated Plasma Osteopontin Level is Associated with Pelvic Inflammatory Disease」主題。共同形成了獨特的指紋。